Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Chronic Obstructive Pulmonary Disease (COPD). Show all posts
Showing posts with label Chronic Obstructive Pulmonary Disease (COPD). Show all posts
Monday, October 7, 2024

FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)

›
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayr...
Wednesday, November 30, 2016

Bevespi Aerosphere Approved by the FDA for Patients with COPD

›
In continuation of my update on formoterol AstraZeneca today announced that the US Food and Drug Administration has approved  Bevespi Ae...
Thursday, September 8, 2016

Bevespi Aerosphere Approved by the FDA for Patients with COPD

›
In continuation of my update on  Formoterol   Formoterol       glycopyrrolate AstraZeneca announced that the US Food and Drug Admini...
Thursday, November 21, 2013

Scientists develop new drug to treat obstructive airway diseases

›
Scientists have developed a new drug (RPL554, see structure) that could treat obstructive airway diseases such as asthma and chronic obstr...
Saturday, May 11, 2013

FDA Approves Breo Ellipta to Treat Chronic Obstructive Pulmonary Disease (COPD)

›
   The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate above structure) and vilanterol (below struct...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.